Meta description: Learn why Spravato prior authorizations are denied and how behavioral health practices can prepare complete documentation, route requests correctly, and track renewals.
Spravato authorization can stall before treatment begins when a request goes to the wrong benefit, lacks required records, or arrives after an authorization period has ended. The best first step is to confirm the member’s benefit and current payer policy, then submit a complete request through the correct channel and track its dates and authorized units. Requirements vary by payer, and the payer’s current policy is the source of truth. Approval can never be guaranteed.
Why is Spravato so hard to get authorized?
Spravato can be difficult to authorize because the process may involve both payer-specific coverage rules and REMS program requirements.
The payer may require documentation supporting medical necessity, prior medication trials, or other criteria. Separately, Spravato is available through a restricted distribution program. The SPRAVATO REMS states that treatment must take place in a certified healthcare setting, and that pharmacies involved in dispensing must also be certified. The practice should confirm that its setting and relevant personnel meet current program requirements.
These are related but distinct checks. REMS certification does not itself establish insurance coverage, and a payer authorization does not replace REMS requirements. Confirm both before scheduling around an expected start date.
For practice teams, the challenge is keeping the pieces together: current payer criteria, complete clinical documentation from the treating provider, the correct submission route, and any setting or pharmacy steps that apply.

Does Spravato fall under the medical or the pharmacy benefit?
Spravato may be handled under the medical benefit or the pharmacy benefit, depending on the payer and the member’s plan.
Do not assume that a process used for one plan will work for another, even when the practice is treating the same medication indication. Before submitting, verify the member’s active coverage and ask the plan which benefit applies, where the prior authorization must be sent, and whether a specific specialty pharmacy or distribution pathway is required.
Document the response, including the date, representative or source, and any reference number provided. Then follow the payer’s current policy and instructions. If the plan’s materials are unclear or conflict with what a representative says, ask for clarification before sending the request.
Routing matters because a clinically complete request can still be delayed if it lands with the wrong review team. Establishing the correct route upfront can save staff from repeated calls and resubmissions.
Why do Spravato prior authorizations get denied?
Spravato prior authorizations are commonly denied or delayed when required criteria or records are missing, unclear, outdated, or sent through the wrong benefit channel.
Before submission, check for issues such as:
- The request went to the medical benefit when the plan requires the pharmacy benefit, or vice versa.
- Required medication-trial history is incomplete or does not clearly match the payer’s criteria.
- Supporting documentation does not address the plan’s medical-necessity requirements.
- REMS setting or pharmacy information is missing when requested.
- The request uses an outdated form or policy checklist.
- The authorization period, units, or dates from an earlier approval were not reviewed.
Step therapy rules vary. A payer may ask for documentation of failed medication trials, but the number of trials, required details, and any exceptions differ by plan and indication. Do not rely on a general checklist as a substitute for the member’s current policy.

How do you get Spravato approved the first time?
To give a Spravato request the best chance of a timely, complete review, verify the benefit, check the current policy, and submit all requested documentation through the correct channel.
Use a front-end checklist:
- Confirm eligibility and benefit routing. Verify active coverage and whether the request belongs to the medical or pharmacy benefit. Confirm any required specialty pharmacy process.
- Review the payer’s current policy. Check the plan’s criteria, required forms, submission instructions, and documentation list. Requirements vary by payer, so the current payer policy is the source of truth.
- Confirm REMS readiness. Check the REMS program requirements for the healthcare setting and any relevant pharmacy steps.
- Coordinate supporting records. Ask the treating provider for documentation that addresses the payer’s medical-necessity criteria. If the policy requires prior medication trials, make sure the records clearly document the information requested. Administrative staff should not create or interpret clinical rationale.
- Review the packet before sending. Confirm that forms are complete, attachments are legible, and all requested identifiers and contact details are consistent.
- Record the submission and follow up. Note when and where the request was sent, the expected review timeline, and any reference number. Follow up through the payer’s stated process if no decision arrives within its timeframe.
A first-pass checklist cannot guarantee approval. It can help reduce avoidable delays caused by missing information or misrouting.
Why reauthorization is where practices lose the most money
Reauthorization is a common front-end risk because an approval has an end date, and the next request may need updated documentation before the current authorization expires.
Set up a shared tracker as soon as an authorization is received. Record its effective and end dates, approved units or visits as defined by the payer, benefit route, and any renewal requirements. Assign a staff owner and schedule reminders early enough to gather documentation and resolve questions before the authorization lapses.
Do not treat an earlier approval as proof that the next request will be approved. Check the current policy again, because requirements can change, and confirm what information the payer expects for continuation. Build the renewal process around the payer’s timeline rather than waiting for the last scheduled treatment or the expiration date.
This is where a reliable patient-access workflow matters. As a patient-access leader with more than 20 years of experience, I have seen how easily an authorization date can get buried in a busy front desk. A simple owner, tracker, and reminder process makes that risk visible before it disrupts operations.

The bottom line
A smoother Spravato authorization process starts with careful benefit verification, current payer criteria, complete supporting documentation, REMS readiness, and active tracking of authorization dates and units. Requirements vary by payer, so the payer’s current policy is always the source of truth. No workflow can guarantee approval, but a consistent front-end process can help prevent avoidable delays and lapses.
FAQ
Does REMS certification guarantee insurance approval?
No. REMS certification and payer authorization are separate requirements, and the payer’s coverage criteria still apply.
Should a practice assume Spravato uses the medical benefit?
No. The benefit route varies by plan, so verify it with the payer before submitting the request.
When should a practice begin reauthorization?
Start early enough to meet the payer’s stated review timeline and gather any required documentation before the current authorization expires.
If your team wants help tightening its Spravato authorization workflow, message me to learn how Almonord supports behavioral health practices with front-end prior authorization and tracking.
Does a completed checklist mean the request will be approved?
No. A complete, correctly routed request supports a timely review, but approval is never guaranteed and the payer's decision still applies.
What should be recorded in an authorization tracker?
Record the effective and end dates, authorized units as defined by the payer, the benefit route, renewal requirements, and the staff member who owns the follow-up.
Prevention First. Not Damage Control.
This article is for informational purposes only. It is not medical, legal, or compliance advice. Requirements vary by payer, and the payer's current policy is the source of truth. Confirm applicable requirements with your payer contracts and qualified counsel.

